Glycogen storage disease types I and II: Treatment updates

被引：50

作者：

Koeberl, D. D. ^{[1
]}

Kishnani, P. S.

Chen, Y. T.

机构：

[1] Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27710 USA

[2] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan

来源：

JOURNAL OF INHERITED METABOLIC DISEASE | 2007年 / 30卷 / 02期

关键词：

D O I：

10.1007/s10545-007-0519-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Prior to 2006 therapy for glycogen storage diseases consisted primarily of dietary interventions, which in the case of glycogen storage disease (GSD) type 11 (GSD 11; Pompe disease) remained essentially palliative. Despite improved survival and growth, long-term complications of GSD type I (GSD 1) have not responded to dietary therapy with uncooked cornstarch or continuous gastric feeding. The recognized significant risk of renal disease and liver malignancy in GSD I has prompted efforts towards curative therapy, including organ transplantation, in those deemed at risk. Results of clinical trials in infantile Pompe disease with alglucosidase alfa (Myozyme) showed prolonged survival reversal of cardiomyopathy, and motor gains. This resulted in broad label approval of Myozyme for Pompe disease in 2006. Furthermore, the development of experimental therapies, such as adeno-associated virus (AAV) vector-mediated gene therapy, holds promise for the availability of curative therapy in GSD I and GSD II/Pompe disease in the future.

引用

页码：159 / 164

页数：6

共 45 条

[21] Recombinant human acid α-glucosidase -: Major clinical benefits in infantile-onset Pompe disease [J].

Kishnani, P. S. ;

Corzo, D. ;

Nicolino, M. ;

Byrne, B. ;

Mandel, H. ;

Hwu, W. L. ;

Leslie, N. ;

Levine, J. ;

Spencer, C. ;

McDonald, M. ;

Li, J. ;

Dumontier, J. ;

Halberthal, M. ;

Chien, Y. H. ;

Hopkin, R. ;

Vijayaraghavan, S. ;

Gruskin, D. ;

Bartholomew, D. ;

van der Ploeg, A. ;

Clancy, J. P. ;

Parini, R. ;

Morin, G. ;

Beck, M. ;

De la Gastine, G. S. ;

Jokic, M. ;

Thurberg, B. ;

Richards, S. ;

Bali, D. ;

Davison, M. ;

Worden, M. A. ;

Chen, Y. T. ;

Wraith, J. E. .

NEUROLOGY, 2007, 68 (02) :99-109

[22] A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease [J].

Kishnani, Priya S. ;

Hwu, Wuh-Liang ;

Mandel, Hanna ;

Nicolino, Marc ;

Yong, Florence ;

Corzo, Deyanira .

JOURNAL OF PEDIATRICS, 2006, 148 (05) :671-676

[23] Chinese hamster ovary cell-derived recombinant human acid α-glucosidase in infantile-onset Pompe disease [J].

Kishnani, Priya Sunil ;

Nicolino, Marc ;

Voit, Thomas ;

Rogers, R. Curtis ;

Tsai, Anne Chun-Hui ;

Waterson, John ;

Herman, Gail E. ;

Amalfitano, Andreas ;

Thurberg, Beth L. ;

Richards, Susan ;

Davidson, Mark ;

Corzo, Deyanira ;

Chen, Y. T. .

JOURNAL OF PEDIATRICS, 2006, 149 (01) :89-97

[24] Isolation and nucleotide sequence of canine glucose-6-phosphatase mRNA: Identification of mutation in puppies with glycogen storage disease type Ia [J].

Kishnani, PS ;

Bao, Y ;

Wu, JY ;

Brix, AE ;

Lin, JL ;

Chen, YT .

BIOCHEMICAL AND MOLECULAR MEDICINE, 1997, 61 (02) :168-177

[25] Canine model and genomic structural organization of glycogen storage disease type Ia (GSD Ia) [J].

Kishnani, PS ;

Faulkner, E ;

VanCamp, S ;

Jackson, M ;

Brown, T ;

Boney, A ;

Koeberl, D ;

Chen, YT .

VETERINARY PATHOLOGY, 2001, 38 (01) :83-91

[26] Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse [J].

Lei, KJ ;

Chen, HW ;

Pan, CJ ;

Ward, JM ;

Mosinger, B ;

Lee, EJ ;

Westphal, H ;

Mansfield, BC ;

Chou, JY .

NATURE GENETICS, 1996, 13 (02) :203-209

[27] Glycogenosis storage type I diseases and evolutive adenomatosis: an indication for liver transplantation [J].

Lerut, JP ;

Ciccarelli, O ;

Sempoux, C ;

Danse, E ;

deFlandre, J ;

Horsmans, Y ;

Sokal, E ;

Otte, JB .

TRANSPLANT INTERNATIONAL, 2003, 16 (12) :879-884

[28] Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening [J].

Li, YJ ;

Scott, CR ;

Chamoles, NA ;

Ghavami, A ;

Pinto, BM ;

Turecek, F ;

Gelb, MH .

CLINICAL CHEMISTRY, 2004, 50 (10) :1785-1796

[29] SEQUENCE OF THE CDNA AND 5'-FLANKING REGION FOR HUMAN ACID ALPHA-GLUCOSIDASE, DETECTION OF AN INTRON IN THE 5' UNTRANSLATED LEADER SEQUENCE, DEFINITION OF 18-BP POLYMORPHISMS, AND DIFFERENCES WITH PREVIOUS CDNA AND AMINO-ACID-SEQUENCES [J].

MARTINIUK, F ;

MEHLER, M ;

TZALL, S ;

MEREDITH, G ;

HIRSCHHORN, R .

DNA AND CELL BIOLOGY, 1990, 9 (02) :85-94

[30] Newborn screening for lysosomal storage disorders [J].

Millington, DS .

CLINICAL CHEMISTRY, 2005, 51 (05) :808-809

← 1 2 3 4 5 →